This study is comparing two treatments for localized prostate cancer: Aquablation Therapy and radical prostatectomy. Aquablation Therapy uses a robotic system with a high-velocity waterjet to remove prostate tissue. Radical prostatectomy is surgery to remove the entire prostate gland. You might be able to join if you are a man at least 45 years old with certain types of prostate cancer (Grade Group 1-3) that hasn't spread too far, and you are a candidate for or have chosen prostatectomy. The study will look at how well each treatment prevents urinary incontinence (leaking urine) and erectile dysfunction (problems with erections) after 6 months. The study aims to enroll 280 participants.

Study design

This is a randomized clinical trial, meaning participants will be randomly assigned to receive either Aquablation Therapy or radical prostatectomy. It is a multicenter study, involving several different locations.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for up to 10 years after their treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.